Tiwari Vivek, Sharma Pankaj Kumar, Sampath Kumar Venkatesan, Poudel Rishi R, Meena Sanjay, Banjara Roshan
Department of Orthopedics, All India Institute of Medical Sciences, Nagpur, IND.
Department of Orthopedics, All India Institute of Medical Sciences, Bathinda, IND.
Cureus. 2022 May 23;14(5):e25245. doi: 10.7759/cureus.25245. eCollection 2022 May.
The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has drastically affected healthcare delivery to cancer patients, including those with malignant bone tumors, worldwide. Such cancer patients are more susceptible to COVID-19 infection and risk contracting the severe disease, but their holistic tumor management has also suffered a significant impact. Because of the acute shortage of healthcare resources due to their diversion in COVID management, substantial changes are needed in various aspects of management for high-grade tumor patients, particularly in developing countries and population-dense regions, so that their evidence-based appropriate treatment is ensured. Owing to a lack of consensus regarding the ideal course of action for the management of malignant bone tumors in the current situation, many such patients often get neglected, leading to loss of life/limb. This review elaborates on various guidelines proposed by different healthcare organizations and institutes regarding the modified care pathways for malignant bone neoplasms in the current coronavirus pandemic. The early published results of these modified care pathways and the changes in the oncology practice brought about by the pandemic are also discussed.
由严重急性呼吸综合征冠状病毒2（SARS-CoV-2）引起的2019冠状病毒病疫情，已对全球癌症患者（包括恶性骨肿瘤患者）的医疗服务产生了巨大影响。这类癌症患者更容易感染2019冠状病毒病，且有感染重症的风险，但其整体肿瘤管理也受到了重大影响。由于新冠疫情防控导致医疗资源严重短缺，高级别肿瘤患者的管理在各个方面都需要做出重大改变，特别是在发展中国家和人口密集地区，以确保他们能得到基于证据的恰当治疗。由于目前对于恶性骨肿瘤管理的理想行动方案缺乏共识，许多这类患者常常被忽视，导致生命/肢体丧失。本综述详细阐述了不同医疗组织和机构针对当前冠状病毒大流行中恶性骨肿瘤改良护理途径提出的各种指南。还讨论了这些改良护理途径的早期公布结果以及疫情给肿瘤学实践带来的变化。
